Format

Send to

Choose Destination
See comment in PubMed Commons below
Drug Des Devel Ther. 2013 Apr 12;7:325-38. doi: 10.2147/DDDT.S31064. Print 2013.

Current and emerging pharmacological treatments for sarcoidosis: a review.

Author information

1
Division of Pulmonary and Critical Care Medicine, Albany Medical College, Albany, NY 12208, USA.

Abstract

The treatment of sarcoidosis is not standardized. Because sarcoidosis may never cause significant symptoms or organ dysfunction, treatment is not mandatory. When treatment is indicated, oral corticosteroids are usually recommended because they are highly likely to be effective in a relative short period of time. However, because sarcoidosis is often a chronic condition, long-term treatment with corticosteroids may cause significant toxicity. Therefore, corticosteroid sparing agents are often indicated in patients requiring chronic therapy. This review outlines the indications for treatment, corticosteroid treatment, and corticosteroid sparing treatments for sarcoidosis.

KEYWORDS:

corticosteroids; drugs; extrapulmonary sarcoidosis; pulmonary sarcoidosis; treatment

PMID:
23596348
PMCID:
PMC3627473
DOI:
10.2147/DDDT.S31064
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Dove Medical Press Icon for PubMed Central
    Loading ...
    Support Center